7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof

7-([1,2,4,]triazolo[1,5,-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4- tetrahydroisoquinoline and use thereof

596104 Disclosed herein are stereoisomers of 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydroisoquinoline and the use thereof in the treatment of neurological and physiological disorders such as a disorder which is created by or is dependent upon decreased availabili...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIU SHUANG, MOLINO BRUCE F, NACRO KASSOUM
Format: Patent
Sprache:eng
Schlagworte:
AGRICULTURE
ANIMAL HUSBANDRY
BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES
CHEMISTRY
FISHING
FORESTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HUNTING
METALLURGY
ORGANIC CHEMISTRY
PEST REPELLANTS OR ATTRACTANTS
PLANT GROWTH REGULATORS
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTSTHEREOF
TRAPPING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:596104 Disclosed herein are stereoisomers of 7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichloro-phenyl)-1,2,3,4-tetrahydroisoquinoline and the use thereof in the treatment of neurological and physiological disorders such as a disorder which is created by or is dependent upon decreased availability of norepinephrine, dopamine or serotonin. Methods of making these compounds and crystalline forms SA-I and N-2 are also described.